Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Soleno Therapeutics Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 21 | 23 | +2 |
| Shares | 3.32M | 5.10M | +1.78M (+53.7%) |
| Value | $7.06M | $21.8M | +$14.7M (+208.8%) |
New holders (3)
Institutions that held Soleno Therapeutics Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Perceptive Advisors LLC | 2,207,753 | $9.47M | 0.28% |
| VisionPoint Advisory Group, LLC | 168 | $721 | 0.00% |
| UBS Group AG | 15 | $64 | 0.00% |
Sold out (1)
Institutions that held Soleno Therapeutics Inc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Clayton Partners LLC | 92,772 | $198.5K |